"The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-solving approach, addressing practical considerations and guidelines. Emphasis will be placed on open discussion, ensuring a maximum level of interaction between faculty and registered participants. Chairs: Caron Jacobson, Ulrich Jäger, Marie José Kersten"
"CAR-T cells and bispecific antibodies have advanced our therapeutic armamentarium for haematological malignancies.
The programme of this ESH conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies and in solid tumours will also be discussed.
The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-solving approach, addressing practical considerations and guidelines. Emphasis will be placed on open discussion, including a maximum level of interaction between faculty and registered participants.
In addition to the scientific and medical issues addressed during the conference, the questions of affordability of and access to these novel expensive treatments will be tackled by medical experts, representatives of patient organisations, economists, authorities and industry.
Continuing Medical Education (CME) credit points will be awarded to physicians for the time they will spend at the meeting improving their knowledge and skills. ESH is a provider of the European Hematology CME system.
Posters and Brief Oral Communications:
Registered participants are invited to submit their clinical cases and abstracts abstracts. Selected clinical cases and abstracts will be presented as brief oral communications or posters.
Call for abstracts and clinical cases: June 29, 2025 (23:59 CEST)
The meeting will be of interest to:
• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
• Junior scientists and clinicians (MD, PhD)
• PhD candidates and clinical residents still in-training
Conference Main Scientific Topics:
- Non-hodgkin lymphoma
- Multiple myeloma
- Novel indications of CAR T-cell therapy
- 1st line high-risk large B-cell lymphoma
- Access to CAR-T and bispecific across the globe
- Predictors of response and toxicity of CAR and bispecific
- Access issues in CAR T-cell treatment
- CAR-T vs bispecific antibody in multiple myeloma
- Real world data for CAR-T and bispecific
- Next Generation of CAR T-cell and bispecific antibody therapy
The programme will include:
– Keynote Lecture
– Plenary Sessions
– Meet the Expert Sessions
– Roundtables
– Debates
– Mentored Poster Walks
– Brief Oral Communications
– Voting technology
For queries please email: [email protected]

External Events

Nov 26
24
25
26
Jan 27
18
19
28
Feb 27
1
24
25
26
November 24th 2026
Current Thinking in Haematological Malignancies...
The programme for this meeting has been designed to combine high calibre lectures and interactive discussions to prov...
Details
November 25th 2026
RCPath & SHOT Advances in Transfusion Symposium...
This popular biennial symposium brings together expert speakers in transfusion medicine and science. It is suitable f...
Details
November 26th 2026
Glasgow Surgical Forum 2026
Advances in Surgical Oncology: Evidence, Practice and Outcomes'. An essential update for the general and specialist s...
Details
November 26th 2026
UK Blood Cancer ECR Network Launch
We are excited to launch the UKBCRN ECR network, which aims to support early-career researchers with an interest in h...
Details
November 26th 2026
UK Blood Cancer ECR Network Launch (1)
We are excited to launch the UKBCRN ECR network, which aims to support early-career researchers with an interest in h...
Details
January 18th 2027
Multiple Myeloma Preceptorship 2027
Join us for our face-to-face preceptorship programme. You will receive the latest updates regarding Multiple Myeloma...
Details
January 19th 2027
Post ASH Significant Highlights (6)
An annual January event , where highlights will be presented from the ASH meeting. The aim of this 2 day event is to...
Details
January 28th 2027
Innovations in Transplant and Cellular Therapy
The programme for the Innovations in Transplant and Cellular Therapy Day will focus on novel therapies, transplant co...
Details
February 1st 2027
CLL and Lymphomas in Practice Preceptorship 2027
Join us to explore the latest approaches to managing chronic lymphocytic leukaemia (CLL), follicular lymphoma, margin...
Details
February 24th 2027
UCLH: Challenges in MPN - Medical
Join us for a clinically focused and highly interactive study day dedicated to the management of complex MPN (myelopr...
Details
February 25th 2027
UCLH: Challenges in MPN - Nursing
This study day has been designed specifically for Clinical Nurse Specialists working with patients living with myelop...
Details
February 26th 2027
OB Shock: Hemorrhage, Hemodynamics & Hemostasis...
This multidisciplinary workshop advances clinical decision-making in complex obstetric hemorrhage through applied coa...
Details